Using surrogate end-points for clinical trials represents a massive boost for pharmaceutical company profits. So, they work hard, behind the scenes, to ensure that this happens

In this presentation from 2019, Greg Glassman tells the story of how bad science, primarily in the form of corruption, led him to make business decisions to fight to protect his affiliate gyms.

In this video Emily explains all-cause mortality, and how it impacts decision making for medical intervention.

Mark Bell's Power Project Podcast ep 1002. Greg Glassman, Mark Bell, Nsima Inyand, and Andrew Zaragoza talk about how and why Greg created CrossFit and why Greg believes science is broken.

Efforts over the past decade to characterize the genetic alterations in human cancers have led to a better understanding of molecular drivers of this complex […]

The end of the COVID-19 pandemic is often associated with the creation and distribution of mRNA vaccines. But were the vaccines actually as effective as they're claimed to be?

By Norbert L. Kerr Summary This paper by psychologist Norbert Kerr discusses the emerging practice in science of asserting a hypothesis after an experiment has […]